MSUXF(MSUXF)
MSUXF
No analyst ratings available
No analyst price targets available for MSUXF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $518.21B | $554.44B | $583.38B | $669.68B | $725.46B |
| Low | $506.45B | $542.40B | $570.44B | $654.82B | $709.36B |
| High | $538.12B | $573.72B | $604.69B | $694.14B | $751.96B |
| EBITDA Avg | $80.72B | $88.85B | $93.22B | $120.46B | $136.37B |
| Low | $78.98B | $86.89B | $91.15B | $117.63B | $133.13B |
| High | $83.57B | $92.07B | $96.63B | $125.10B | $141.71B |
| EBIT Avg | $60.33B | $68.07B | $71.90B | $98.01B | $112.58B |
| Low | $58.59B | $66.11B | $69.83B | $95.19B | $109.33B |
| High | $63.18B | $71.30B | $75.31B | $102.66B | $117.91B |
| Net Income Avg | $45.18B | $51.00B | $53.88B | $73.49B | $84.43B |
| Low | $43.88B | $49.53B | $52.33B | $71.37B | $81.99B |
| High | $47.33B | $53.42B | $56.44B | $76.98B | $88.43B |
| EPS Avg | $166.40 | $187.83 | $198.43 | $270.64 | $310.92 |
| Low | $161.60 | $182.41 | $192.71 | $262.83 | $301.96 |
| High | $174.31 | $196.75 | $207.85 | $283.49 | $325.69 |
| Analysts (Rev / EPS) | 3 / 1 | 5 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $126.57B | $131.25B | $134.80B |
| Low | $123.40B | $128.50B | $131.71B |
| High | $132.79B | $135.32B | $140.20B |
| EBITDA Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EBIT Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 3 / — | 3 / — | 1 / — |